Episil Technologies Inc.
TPEx:3707.TWO
73.5 (TWD) • At close November 20, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7,080.216 | 8,879.881 | 7,269.4 | 5,741.46 | 5,419.225 | 6,436.456 | 5,273.623 | 4,377.748 | 3,191.954 | 749.873 | 3,700.001 | 3,645.05 | 4,725.554 | 5,331.428 | 3,010.15 |
| Cost of Revenue
| 6,271.873 | 7,143.887 | 6,279.477 | 5,749.91 | 5,511.19 | 5,562.443 | 4,710.527 | 4,206.268 | 3,282.206 | 760.725 | 3,501.475 | 3,483.085 | 4,179.005 | 4,415.142 | 3,334.338 |
| Gross Profit
| 808.343 | 1,735.994 | 989.923 | -8.45 | -91.965 | 874.013 | 563.096 | 171.48 | -90.252 | -10.852 | 198.526 | 161.965 | 546.549 | 916.286 | -324.188 |
| Gross Profit Ratio
| 0.114 | 0.195 | 0.136 | -0.001 | -0.017 | 0.136 | 0.107 | 0.039 | -0.028 | -0.014 | 0.054 | 0.044 | 0.116 | 0.172 | -0.108 |
| Reseach & Development Expenses
| 222.572 | 144.188 | 124.353 | 127.446 | 133.272 | 176.509 | 166.24 | 154.315 | 151.338 | 37.943 | 59.097 | 58.583 | 64.293 | 78.408 | 64.481 |
| General & Administrative Expenses
| 366.214 | 382.102 | 288.363 | 262.328 | 267.734 | 291.185 | 263.284 | 266.999 | 232.661 | 50.742 | 152.013 | 148.863 | 163.465 | 160.589 | 136.82 |
| Selling & Marketing Expenses
| 85.086 | 107.148 | 91.537 | 80.19 | 88.31 | 101.052 | 97.843 | 101.054 | 65.423 | 17.498 | 63.266 | 63.354 | 67.692 | 73.805 | 48.516 |
| SG&A
| 450.159 | 489.25 | 379.9 | 342.518 | 356.044 | 392.237 | 361.127 | 368.053 | 298.084 | 68.24 | 215.279 | 212.217 | 231.157 | 234.394 | 185.336 |
| Other Expenses
| 33.974 | 191.541 | 24.51 | 19.615 | 23.017 | 56.353 | -21.816 | 16.38 | 40.086 | 13.001 | 17.291 | 6.816 | -0.738 | 5.412 | -6.806 |
| Operating Expenses
| 672.731 | 633.438 | 504.253 | 469.964 | 489.316 | 568.746 | 527.367 | 522.368 | 449.422 | 106.183 | 274.376 | 270.8 | 295.45 | 312.802 | 249.817 |
| Operating Income
| 135.612 | 1,319.234 | 517.409 | -452.257 | -558.602 | 305.267 | 35.729 | -350.888 | -539.674 | -117.035 | -75.85 | -108.835 | 251.099 | 603.484 | -574.005 |
| Operating Income Ratio
| 0.019 | 0.149 | 0.071 | -0.079 | -0.103 | 0.047 | 0.007 | -0.08 | -0.169 | -0.156 | -0.02 | -0.03 | 0.053 | 0.113 | -0.191 |
| Total Other Income Expenses Net
| 41.814 | -32.696 | -29.412 | -37.751 | -43.638 | 34.772 | -48.007 | -10.26 | -4.162 | 12.589 | 15.06 | 3.512 | 13.491 | -19.669 | -33.761 |
| Income Before Tax
| 177.426 | 1,286.538 | 487.997 | -490.008 | -602.24 | 340.039 | -12.278 | -361.148 | -543.836 | -104.446 | -60.79 | -105.323 | 264.59 | 583.815 | -607.766 |
| Income Before Tax Ratio
| 0.025 | 0.145 | 0.067 | -0.085 | -0.111 | 0.053 | -0.002 | -0.082 | -0.17 | -0.139 | -0.016 | -0.029 | 0.056 | 0.11 | -0.202 |
| Income Tax Expense
| 43.673 | 180.451 | 100.518 | -5.221 | 0.535 | 100.788 | 33.07 | 28.859 | 4.727 | 22.828 | 14.937 | -0.001 | -0.028 | -0.057 | 36.803 |
| Net Income
| 67.073 | 1,106.087 | 387.479 | -484.787 | -602.775 | 71.203 | -115.234 | -397.824 | -548.563 | -127.274 | -58.436 | -99.639 | 270.3 | 589.991 | -644.569 |
| Net Income Ratio
| 0.009 | 0.125 | 0.053 | -0.084 | -0.111 | 0.011 | -0.022 | -0.091 | -0.172 | -0.17 | -0.016 | -0.027 | 0.057 | 0.111 | -0.214 |
| EPS
| 0.2 | 3.33 | 1.22 | -1.6 | -2.11 | 0.26 | -0.59 | -2.36 | -3.39 | -0.79 | -0.17 | -0.29 | 0.8 | 1.74 | -1.9 |
| EPS Diluted
| 0.2 | 3.27 | 1.22 | -1.6 | -2.11 | 0.26 | -0.59 | -2.35 | -3.26 | -0.76 | -0.17 | -0.29 | 0.8 | 1.74 | -1.9 |
| EBITDA
| 840.441 | 1,965.516 | 1,166.432 | 178.141 | 21.271 | 798.707 | 348.285 | 29.906 | -288.9 | -45.276 | 220.466 | 254.254 | 729.607 | 1,115.97 | -30.36 |
| EBITDA Ratio
| 0.119 | 0.221 | 0.16 | 0.031 | 0.004 | 0.124 | 0.066 | 0.007 | -0.091 | -0.06 | 0.06 | 0.07 | 0.154 | 0.209 | -0.01 |